Predicting the Probability that a Chemical Causes Steatosis Using Adverse Outcome Pathway Bayesian Networks (AOPBNs)
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Predicting the Probability that a Chemical Causes Steatosis Using Adverse Outcome Pathway Bayesian Networks (AOPBNs)
Authors
Keywords
-
Journal
RISK ANALYSIS
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2019-11-13
DOI
10.1111/risa.13423
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Drug-induced liver injury: recent advances in diagnosis and risk assessment
- (2017) Gerd A Kullak-Ublick et al. GUT
- The Reactome Pathway Knowledgebase
- (2017) Antonio Fabregat et al. NUCLEIC ACIDS RESEARCH
- How well can carcinogenicity be predicted by high throughput “characteristics of carcinogens” mechanistic data?
- (2017) Richard A. Becker et al. REGULATORY TOXICOLOGY AND PHARMACOLOGY
- Editor’s Highlight: Mechanistic Toxicity Tests Based on an Adverse Outcome Pathway Network for Hepatic Steatosis
- (2017) Michelle M. Angrish et al. TOXICOLOGICAL SCIENCES
- Integrated decision strategies for skin sensitization hazard
- (2016) Judy Strickland et al. JOURNAL OF APPLIED TOXICOLOGY
- Using In Vitro High-Throughput Screening Data for Predicting Benzo[k]Fluoranthene Human Health Hazards
- (2016) Lyle D. Burgoon et al. RISK ANALYSIS
- Using ToxCast™ Data to Reconstruct Dynamic Cell State Trajectories and Estimate Toxicological Points of Departure
- (2015) Imran Shah et al. ENVIRONMENTAL HEALTH PERSPECTIVES
- The Dual Role of Nrf2 in Nonalcoholic Fatty Liver Disease: Regulation of Antioxidant Defenses and Hepatic Lipid Metabolism
- (2015) Sílvia S. Chambel et al. Biomed Research International
- Hypobetalipoproteinemia and abetalipoproteinemia
- (2014) Francine K. Welty CURRENT OPINION IN LIPIDOLOGY
- Sterol Regulatory Element-binding Protein-1 (SREBP-1) Is Required to Regulate Glycogen Synthesis and Gluconeogenic Gene Expression in Mouse Liver
- (2014) Rafaela Ruiz et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Adverse Outcome Pathway (AOP) Development I: Strategies and Principles
- (2014) Daniel L. Villeneuve et al. TOXICOLOGICAL SCIENCES
- Prevalence of Nonalcoholic Fatty Liver Disease in the United States: The Third National Health and Nutrition Examination Survey, 1988–1994
- (2013) Mariana Lazo et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- Mechanisms of hepatic triglyceride accumulation in non-alcoholic fatty liver disease
- (2013) Yuki Kawano et al. JOURNAL OF GASTROENTEROLOGY
- Nrf2 Inhibits LXRα-Dependent Hepatic Lipogenesis by Competing with FXR for Acetylase Binding
- (2011) Hee Yeon Kay et al. ANTIOXIDANTS & REDOX SIGNALING
- Ablation of PI3K p110- Prevents High-Fat Diet-Induced Liver Steatosis
- (2011) M. Chattopadhyay et al. DIABETES
- Genetic control ofde novolipogenesis: role in diet-induced obesity
- (2010) Maggie S. Strable et al. CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Adverse outcome pathways: A conceptual framework to support ecotoxicology research and risk assessment
- (2010) Gerald T. Ankley et al. ENVIRONMENTAL TOXICOLOGY AND CHEMISTRY
- An Introduction to Causal Inference
- (2010) Judea Pearl
- Peroxisome Proliferator-Activated Receptor Alpha Target Genes
- (2010) Maryam Rakhshandehroo et al. PPAR Research
- Interrelationship between Liver X Receptor α, Sterol Regulatory Element-binding Protein-1c, Peroxisome Proliferator-activated Receptor γ, and Small Heterodimer Partner in the Transcriptional Regulation of Glucokinase Gene Expression in Liver
- (2009) Tae-Hyun Kim et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- mTOR signaling at a glance
- (2009) M. Laplante et al. JOURNAL OF CELL SCIENCE
- Protein Kinase C Function in Muscle, Liver, and -Cells and Its Therapeutic Implications for Type 2 Diabetes
- (2008) C. Schmitz-Peiffer et al. DIABETES
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More